Blood thinners carry several long-term side effects beyond just the well-known bleeding risk. The specific effects depend on which type you take, how long you take it, and your overall health. The two main classes, older vitamin K antagonists like warfarin and newer direct oral anticoagulants (often called DOACs), share some risks but differ in important ways when it comes to bone health, gut problems, and the daily management they require.
Bleeding Risk Over Time
The most significant long-term side effect of any blood thinner is an increased risk of bleeding. This includes minor nuisances like bruising easily, nosebleeds, and bleeding gums, but also serious events like gastrointestinal bleeds or bleeding in the brain. Major bleeding is defined as bleeding severe enough to require hospitalization, and it can occur in the digestive tract, the skull, the space around the spine, or inside joints.
The annual risk of major bleeding varies by drug. In studies of patients with serious kidney disease, warfarin caused major bleeding at a rate of about 2.9 per 100 people per year. Apixaban (Eliquis) came in lower at roughly 1.5 per 100 person-years, while rivaroxaban (Xarelto) was higher at about 4.9 per 100 person-years in that same population. These numbers shift depending on your age, kidney function, and other medications, but the pattern holds broadly: apixaban tends to carry the lowest major bleeding risk among the commonly prescribed options.
Older adults face particular concern. Research published in the Journal of Thrombosis and Haemostasis found that in patients over 80, warfarin may cause more major bleeding than antiplatelet drugs like aspirin. And notably, even antiplatelet drugs, which are sometimes perceived as gentler, carry a risk of major bleeding that is close to or equal to that of full anticoagulants. The only clear exception is intracranial bleeding, which is lower with antiplatelets.
Gastrointestinal Problems
Stomach and intestinal bleeding is the most common serious bleeding complication during long-term use. A large population-based study published in The BMJ found gastrointestinal bleeding rates of about 7 cases per 100 person-years for warfarin users and 9 per 100 person-years for dabigatran (Pradaxa) users. Rivaroxaban had the lowest observed rate at about 3.4 per 100 person-years, though after adjusting for other health differences, the statistical gap between rivaroxaban and warfarin narrowed to essentially no difference.
Beyond major bleeds, many people on long-term blood thinners experience chronic low-grade GI irritation: heartburn, stomach discomfort, or occasional blood in the stool that doesn’t rise to the level of a medical emergency but affects quality of life. If you notice dark or tarry stools, or vomit that looks like coffee grounds, those are signs of GI bleeding that need prompt attention.
Bone Loss and Osteoporosis
This is a side effect many people don’t expect. Warfarin specifically interferes with vitamin K, which your body needs not only for blood clotting but also for building and maintaining strong bones. Vitamin K activates proteins that help minerals bind to bone tissue. By blocking this process, long-term warfarin use can weaken bones and increase osteoporosis risk.
A study in the Journal of the American Heart Association found that newer DOACs were associated with an 18% lower risk of osteoporosis compared to warfarin. The benefit varied by specific drug: rivaroxaban lowered osteoporosis risk by about 32%, apixaban by 62%, while dabigatran showed no meaningful difference from warfarin. Importantly, the longer someone stayed on warfarin instead of a DOAC, the wider the gap in bone health became. After one year, the protective advantage of DOACs over warfarin was statistically clear and growing.
If you’ve been on warfarin for years, this is worth discussing with your doctor, especially if you already have risk factors for osteoporosis like older age, low body weight, or a family history of fractures.
Hair Loss
Hair thinning is a recognized side effect of warfarin and heparin, though it’s not common enough to make most warning labels prominent. The mechanism is thought to be telogen effluvium, a process where a trigger pushes hair follicles prematurely into their resting phase. The hair then falls out about two to four months later. The same process can be triggered by surgery, high fevers, or major blood loss, so it can be hard to pin down the exact cause.
Newer DOACs like rivaroxaban, dabigatran, and apixaban are not officially associated with hair loss, though drug safety agencies have flagged scattered reports and continue to monitor for a possible link. If you’re experiencing noticeable hair thinning on warfarin, switching to a DOAC may help, though this decision depends on your full medical picture.
Kidney and Liver Monitoring
Most DOACs are processed through the liver, and all are cleared to some degree by the kidneys. Over years of use, declining kidney function can cause drug levels to build up in your body, raising bleeding risk without any change in your dose. The American College of Cardiology recommends checking kidney function at least every six months for anyone on a DOAC. Liver function testing every six to twelve months is also recommended for people who have, or are at risk for, liver problems.
Warfarin is less dependent on kidney function for clearance, which is one reason it’s still sometimes preferred for people with advanced kidney disease. But warfarin requires its own monitoring burden: regular blood tests (INR checks) to make sure the dose keeps you in the therapeutic range, often every few weeks for as long as you take it.
Drug and Supplement Interactions
Long-term blood thinner use means long-term vigilance about what else you put in your body. Common over-the-counter pain relievers like ibuprofen (Advil, Motrin), naproxen (Aleve), and even aspirin can amplify bleeding risk significantly. Acetaminophen (Tylenol) can also interact with blood thinners, though the effect is generally milder.
Cold medicines, stomach remedies like Pepto-Bismol, and laxatives can all pose problems. So can supplements that seem harmless: garlic, ginkgo biloba, green tea, and standard multivitamins all have the potential to alter how your blood thinner works. This doesn’t mean you can never take a multivitamin, but you should keep your intake consistent and let your medical team know what you’re using.
Dietary Considerations With Warfarin
If you take warfarin specifically, vitamin K intake matters. You don’t need to avoid vitamin K-rich foods like broccoli, Brussels sprouts, asparagus, or leafy greens. The key is consistency. Eating a large salad every day is fine. Eating no greens for a week and then having a spinach binge is not, because the sudden spike in vitamin K can make warfarin less effective and increase your clotting risk.
The recommended daily intake of vitamin K is 120 micrograms for men and 90 micrograms for women. Certain beverages also matter: green tea, chamomile tea, cranberry juice, and grapefruit juice can all interfere with warfarin’s effectiveness. DOACs do not interact with vitamin K, so these dietary restrictions don’t apply if you take apixaban, rivaroxaban, or dabigatran. For many people, this dietary freedom is one of the practical advantages of newer blood thinners over warfarin.
How Side Effects Compare by Drug Type
- Warfarin: Higher osteoporosis risk, dietary restrictions around vitamin K, hair loss possible, requires frequent blood monitoring, and carries higher intracranial bleeding risk than most DOACs.
- Apixaban (Eliquis): Lowest major bleeding rates in most comparisons, significant bone-protective advantage over warfarin, no dietary vitamin K restrictions, but still requires periodic kidney and liver checks.
- Rivaroxaban (Xarelto): Good bone health profile compared to warfarin, but higher major bleeding rates than apixaban in head-to-head data. Lower fatal bleeding risk than warfarin in clinical trials.
- Dabigatran (Pradaxa): Higher gastrointestinal bleeding rates than warfarin in clinical trials, no clear bone advantage over warfarin, but lower intracranial bleeding risk.
No blood thinner is free of long-term side effects. The trade-off is always between the risks of the medication and the risks of the clots it prevents, which can include stroke, pulmonary embolism, or death. The right choice depends on your specific condition, kidney function, age, and what other medications you take.